Daniel Pollyea, MD, MS
Professor of Medicine
Clinical Director of Leukemia Services
Associate Chief of Clinical Affairs
Robert H. Allen MD Chair in Hematology Research
Division of Hematology
University of Colorado School of Medicine
Daniel Pollyea, MD, MS: consultant/advisor/speaker: AbbVie, Arcellx, AstraZeneca, BeiGene, BerGen Bio, Bristol-Myers Squibb, Genentech, Hibercell, Immunogen, Jazz, Kura, LINK, Magenta, Medivir, Novartis, Qihan, Ryvu, Syros, Zentalis; researcher: AbbVie, Bristol-Myers Squibb, Karyopharm, Teva; data and safety monitoring boards: Aptevo, Glycomimetics.